new sport betting app
UCF, LSU face off with improved focus in mind
By KELVIN CHAN, Business Writer LONDON (AP) — Looking for a new social media platform because X, Threads and Mastodon just aren’t cutting it? You could try Bluesky . People seeking to avoid chaos, noise and political bluster in the aftermath of the U.S. elections are noticing a different mood on the Bluesky social platform, where the vibe is seemingly welcoming and there are noticeably fewer trolls. The site announced it had rapidly added more than a million new users in the week after Election Day, and has emerged as one of the fastest growing rivals to Elon Musk’s X and similar platforms. If you’re tempted to check out the new space, here’s a guide on how Bluesky works: Maybe you’re not ready to commit to adding yet another social media account. No problem — you can still look around on Bluesky without signing up because all posts and profiles are public. You might get a sense of deja vu because the platform’s look and feel are very similar to X. That should be no surprise because Twitter co-founder Jack Dorsey was an early Bluesky champion. (Dorsey’s no longer involved with Bluesky, which is owned and run by its executive team as a public benefit corporation.) If you take the plunge and get an account, you’ll need a username. You’ll notice Bluesky handles are a little bit different because they end by default in the site’s domain, .bsky.social. You can personalize your handle to make it more memorable, by using your own website’s domain or buying a custom one through Bluesky. But it might not be something most newbie users need or want to do right away. Bluesky boasts that it gives users “algorithmic choice” to tailor the content they’re shown instead of leaving it up to the whims of a centralized system. “Our online experience doesn’t have to depend on billionaires unilaterally making decisions over what we see,” it says . Related Articles What it means is that you can follow custom feeds set up by other users, or design your own. If you tap #Feeds in the menu on the left, you’ll see some default offerings like Cat Pics and Gardening. My Bangers is a list of your most popular posts by likes and Catch Up shows the site’s most popular posts from the past 24 hours. You can find more by doing a search and tapping the Feeds button. There’s also the usual “Discover” feed of suggested posts and a chronological feed of accounts that you follow. To help new users settle in, Bluesky has starter packs of recommended feeds and accounts to follow, which anyone can create and share. They don’t show up in Bluesky’s search results but can be found in directories online . Or someone might share one with you. After I signed up, a colleague pointed me to one for major news outlets . There are tens of thousands of starter packs, ranging from broadly appealing topics like Taylor Swift to niche interests like cargo bikes or U.K. comedians . You can follow the whole pack or scroll down the list to choose individual accounts. What about people you followed on X? There’s a browser extension tool called Sky Follower Bridge that will help you find X users who’ve migrated to Bluesky. But check before clicking the follow button to make sure it’s not a different user using the same display name or handle. Ready to join the conversation? You can write posts or reply to others but keep it short because there’s a limit of 300 characters — 20 more than on X. You can also upload photos and videos, though videos can’t be longer than 60 seconds. GIFs and emojis are, of course, available too. You can still @ people by typing in their username, like posts by tapping a heart icon or use hashtags to highlight a theme. Bluesky has added a menu to hashtags, so when you click on one you’ll get different options for seeing, or muting, posts on that topic. Bluesky’s decentralization ethos extends to the content control options it offers. For starters, users can choose in their settings menu whether to see replies, reposts or quote posts in their feed. Specific words or tags can be muted temporarily, or forever, while accounts can be muted or blocked individually, or in bulk by adding them a moderation list. You can even fine tune the level of adult content that shows up in your feed. Related Articles Bluesky has a team of content moderators to police the site for material that’s illegal or breaks the rules. But it’s also taking a different approach by open sourcing its content moderation system in an attempt to resolve problems with traditional moderation services which it says “lack transparency and user control.” So, individuals or groups can set up their own content filters, or labelers, that go beyond what Bluesky offers. These labelers can be used to categorize content or users, which can then be blocked or hidden. But they could also be used for informational or creative purposes, like curating or verifying content. There are labelers to identify images generated by artificial intelligence or to fact check news posts. You can find lists of labelers online. After I subscribed to a U.S. politics labeler, some posts in my feeds were flagged “!Donald Trump” or “!Democrat politician” and hidden unless I click Show. Follow Kelvin Chan on Bluesky Is there a tech challenge you need help figuring out? Write to us at onetechtip@ap.org with your questions.
Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle Griffin had no trouble getting them. The 38-year-old information technology worker from New Mexico had a prescription. Her pharmacy had the drugs in stock. And her health insurance covered all but $25 to $50 of the monthly cost. For Griffin, the hardest part of using the new drugs wasn’t access. It was finding out that the much-hyped medications didn’t really work for her. “I have been on Wegovy for a year and a half and have only lost 13 pounds,” said Griffin, who watches her diet, drinks plenty of water and exercises regularly. “I’ve done everything right with no success. It’s discouraging.” In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body weight — up to 50 pounds or more in many cases. But roughly 10% to 15% of patients in those trials were “nonresponders” who lost less than 5% of their body weight. Now that millions of people have used the drugs, several obesity experts told The Associated Press that perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications. It’s a little-known consequence of the obesity drug boom, according to doctors who caution eager patients not to expect one-size-fits-all results. “It’s all about explaining that different people have different responses,” said Dr. Fatima Cody Stanford, an obesity expert at Massachusetts General Hospital The drugs are known as GLP-1 receptor agonists because they mimic a hormone in the body known as glucagon-like peptide 1. Genetics, hormones and variability in how the brain regulates energy can all influence weight — and a person’s response to the drugs, Stanford said. Medical conditions such as sleep apnea can prevent weight loss, as can certain common medications, such as antidepressants, steroids and contraceptives. “This is a disease that stems from the brain,” said Stanford. “The dysfunction may not be the same” from patient to patient. Despite such cautions, patients are often upset when they start getting the weekly injections but the numbers on the scale barely budge. “It can be devastating,” said Dr. Katherine Saunders, an obesity expert at Weill Cornell Medicine and co-founder of the obesity treatment company FlyteHealth. “With such high expectations, there’s so much room for disappointment.” That was the case for Griffin, who has battled obesity since childhood and hoped to shed 70 pounds using Wegovy. The drug helped reduce her appetite and lowered her risk of diabetes, but she saw little change in weight. “It’s an emotional roller coaster,” she said. “You want it to work like it does for everybody else.” The medications are typically prescribed along with eating behavior and lifestyle changes. It’s usually clear within weeks whether someone will respond to the drugs, said Dr. Jody Dushay, an endocrine specialist at Beth Israel Deaconess Medical Center. Weight loss typically begins right away and continues as the dosage increases. For some patients, that just doesn’t happen. For others, side effects such as nausea, vomiting and diarrhea force them to halt the medications, Dushay said. In such situations, patients who were counting on the new drugs to pare pounds may think they’re out of options. “I tell them: It’s not game over,” Dushay said. Trying a different version of the new class of drugs may help. Griffin, who didn’t respond well to Wegovy, has started using Zepbound, which targets an additional hormone pathway in the body. After three months of using the drug, she has lost 7 pounds. “I’m hoping it’s slow and steady,” she said. Other people respond well to older drugs, the experts said. Changing diet, exercise, sleep and stress habits can also have profound effects. Figuring out what works typically requires a doctor trained to treat obesity, Saunders noted. “Obesity is such a complex disease that really needs to be treated very comprehensively,” she said. “If what we’re prescribing doesn’t work, we always have a backup plan.” ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
